Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Oncotarget|February 14, 2018
Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatinMiguel Angel Merlos Rodrigo, Simona Dostalova, Hana Buchtelova, et al.Environmental Research|August 10, 2016
Transport phenomena of nanoparticles in plants and animals/humansNaser A Anjum, Miguel Angel Merlos Rodrigo, Amitava Moulick, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2016
Fully automated two-step assay for detection of metallothionein through magnetic isolation using functionalized γ-Fe2O3 particlesMiguel Angel Merlos Rodrigo, Ludmila Krejcova, Jiri Kudr, et al.Oncology Reports|April 17, 2013
Effect of sarcosine on antioxidant parameters and metallothionein content in the PC-3 prostate cancer cell lineNatalia Cernei, Ondrej Zitka, Sylvie Skalickova, et al.FEMS Microbiology Letters|December 10, 2013
Comparison of the effects of silver phosphate and selenium nanoparticles on Staphylococcus aureus growth reveals potential for selenium particles to prevent infectionDagmar Chudobova, Kristyna Cihalova, Simona Dostalova, et al.Scientific Reports|March 22, 2021
Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastomaMiguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, et al.Current Drug Targets|October 2, 2015
Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?Zbynek Heger, Miguel Angel Merlos Rodrigo, Sona Krizkova, et al.Journal of Nanobiotechnology|July 15, 2020
Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cellsYazan Haddad, Marketa Charousova, Hana Zivotska, et al.Biomarker Research|April 9, 2024
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cellsMiguel Angel Merlos Rodrigo, Hana Michalkova, Ana Maria Jimenez Jimenez, et al.Pageof 4